Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 79,989
  • Shares Outstanding, K 280,661
  • Annual Sales, $ 13,657 K
  • Annual Income, $ -4,700 K
  • 60-Month Beta 0.14
  • Price/Sales 3.78
  • Price/Cash Flow N/A
  • Price/Book 14.19
Trade INNO.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $0.00 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2600 +5.77%
on 04/24/24
0.3200 -14.06%
on 04/04/24
-0.0050 (-1.79%)
since 03/22/24
3-Month
0.2550 +7.84%
on 02/13/24
0.3300 -16.67%
on 03/01/24
-0.0300 (-9.84%)
since 01/24/24
52-Week
0.1800 +52.78%
on 07/27/23
0.5200 -47.12%
on 08/28/23
+0.0650 (+30.95%)
since 04/24/23

Most Recent Stories

More News
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to announce that CEO Iris Bincovich will be a...

BABA : 74.63 (+2.92%)
INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to provide the following corporate update:...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "Company" or "Innocan"), is pleased to announce that it will provide a corporate update to the...

INNO.CN : 0.2750 (-3.51%)
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue...

See More

Key Turning Points

3rd Resistance Point 0.3200
2nd Resistance Point 0.3050
1st Resistance Point 0.2900
Last Price 0.2750
1st Support Level 0.2600
2nd Support Level 0.2450
3rd Support Level 0.2300

See More

52-Week High 0.5200
Fibonacci 61.8% 0.3901
Fibonacci 50% 0.3500
Fibonacci 38.2% 0.3099
Last Price 0.2750
52-Week Low 0.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar